Red rice koji extract alleviates hyperglycemia by increasing glucose uptake and glucose transporter type 4 levels in skeletal muscle in two diabetic mouse models
Background: Red rice koji (RRK), prepared by growing Monascus species on steamed rice, has been reported to lower blood glucose levels in diabetic animal models. However, the action mechanism is not yet completely understood.
Objective: The objective of this study was to examine the mechanism underlying the hypoglycemic action of RRK extract in two diabetic animal models: the insulin-deficiency mice, where the insulin deficiency was induced by streptozotocin (STZ), and insulin-resistance mice, where the insulin resistance was induced by a high-fat diet (HFD).
Design: Low (12.5 mg/kg body weight [BW]) and high (50.0 mg/kg BW) doses of RRK extract were orally administered to the mice for 10 successive days (0.25 mL/day/mouse). The protein expression levels of glucose transporter type 4 (GLUT4) in the skeletal muscle and glucose transporter type 2 (GLUT2) in the liver were measured. Blood glucose (BG) levels of STZ-treated mice in insulin tolerance test (ITT) and BG and insulin levels of HFD-fed mice in intraperitoneal glucose tolerance test (IPGTT) were investigated.
Results: In the STZ-treated mice, oral administration of RRK extract lowered BG levels and food intake but increased plasma 1,5-anhydroglucitol level. Moreover, the RRK extract lowered the BG levels of STZ-treated mice as measured by ITT. In the HFD-fed mice, we confirmed that the orally administered RRK extract lowered the BG and the homeostasis model assessment index for insulin resistance. Furthermore, the RRK extract lowered the BG and insulin levels of HFD-fed mice in IPGTT. Regarding the protein levels of GLUT, the orally administered RRK extract increased the GLUT4 level in the skeletal muscle; however, the RRK extract did not alter the GLUT2 level in the liver of either the STZ-treated or the HFD-fed mice.
- Wang TH, Lin TF. Monascus rice products. Adv Food Nutr Res 2007; 53: 123–59. doi: 10.1016/S1043-4526(07)53004-4
- Childress L, Gay A, Zargar A, Ito MK. Review of red yeast rice content and current food and drug administration oversight. J Clin Lipidol 2013; 7(2): 117–22. doi: 10.1016/j.jacl.2012.09.003
- Heber D, Lembertas A, Lu QY, Bowerman S, Go VL. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complement Med 2001; 7(2): 133–9. doi: 10.1089/107555301750164181
- Ma J, Li Y, Ye Q, Li J, Hua Y, Ju D, et al. Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem 2000; 48(11): 5220–25. doi: 10.1021/jf000338c
- Kuba M, Tanaka K, Sesoko M, Inoue F, Yasuda M. Angiotensin I-converting enzyme inhibitory peptides in red-mold rice made by Monascus purpureus. Process Biochem 2009; 44: 1139–43. doi: 10.1016/j.procbio.2009.06.007
- Lee CL, Wang JJ, Kuo SL, Pan TM. Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agent-monacolin K and antiinflammation agent-monascin. Appl Microbiol Biotechnol 2016; 72(6): 1254–62. doi: 10.1007/s00253-006-0404-8
- Taira J, Miyagi C, Aniya Y. Dimerumic acid as an antioxidant from the mold, Monascus anka: the inhibition mechanisms against lipid peroxidation and hemeprotein-mediated oxidation. Biochem Pharmacol 2002; 63(5): 1019–26. doi: 10.1016/S0006-2952(01)00923-6
- Tsukahara M, Shinzato N, Tamaki Y, Namihira T, Matsui T. Red yeast rice fermentation by selected Monascus sp. with deep-red color, lovastatin production but no citrinin, and effect of temperature-shift cultivation on lovastatin production. Appl Biochem Biotechnol 2009; 158(2): 476–82. doi: 10.1007/s12010-009-8553-8
- Shi YC, Pan TM. Anti-diabetic effects of Monascus purpureus NTU 568 fermented products on streptozotocin-induced diabetic rats. J Agric Food Chem 2010; 58(13): 7634–40. doi: 10.1021/jf101194f
- Shi YC, Pan TM. Antioxidant and pancreas-protective effect of red mold fermented products on streptozotocin-induced diabetic rats. J Sci Food Agric 2010; 90(14): 2519–25. doi: 10.1002/jsfa.4115
- Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001; 50(6): 537–46.
- Yoshizaki Y, Kawasaki C, Cheng KC, Ushikai M, Amitani H, Asakawa A, et al. Rice koji reduced body weight gain, fat accumulation, and blood glucose level in high-fat diet-induced obese mice. Peer J 2014; 2: e540. doi: 10.7717/peerj.540
- Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570–81. doi: 10.1001/jama.2009.726
- Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006; 368(9529): 29–36. doi: 10.1016/S0140-6736(06)68967-8
- Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010; 87(1): 15–9. doi: 10.1016/j.diabres.2009.10.006
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047–53. doi: 10.2337/diacare.27.5.1047
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62–69. doi: 10.2337/dc10-S062
- Birnbaum MJ. Diabetes. Dialogue between muscle and fat. Nature 2001; 409(6821): 672–3. doi: 10.1038/35055643
- Shepherd PR, Kahn BB. Mechanisms of disease – glucose transporters and insulin action – implications for insulin resistance and diabetes mellitus. New Engl J Med 1999; 341(4): 248–57. doi: 10.1056/NEJM199907223410406
- Thorens B. GLUT2, glucose sensing and glucose homeostasis. Diabetologia 2015; 58(2): 221–32. doi: 10.1007/s00125-014-3451-1
- Yoshizaki Y, Susuki T, Takamine K, Tamaki H, Ito K, Sameshima Y. Characterization of glucoamylase and alpha-amylase from Monascus anka: enhanced production of alpha-amylase in red koji. J Biosci Bioeng 2010; 110(6): 670–4. doi: 10.1016/j.jbiosc.2010.07.005
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412–19. doi: 10.1007/bf00280883
- Shi YC, Pan TM. Red mold, diabetes, and oxidative stress: a review. Appl Microbiol Biotechnol 2012; 94(1): 47–55. doi: 10.1007/s00253-012-3957-8
- Miadokova E. Isoflavonoids – an overview of their biological activities and potential health benefits. Interdiscip Toxicol 2009; 2(4): 211–18. doi: 10.2478/v10102-009-0021-3
- Cicero AF, Morbini M, Parini A, Urso R, Rosticci M, Grandi E, et al. Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects. Ther Clin Risk Manag 2016; 12: 281–6. doi: 10.2147/TCRM.S91817
- Choi OS, Park SJ, Seo SW, Park CS, Cho JJ, Ahn HJ. The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, lovastatin (statin) ameliorates CCK-induced acute pancreatitis in rats. Biol Pharm Bull 2005; 28(8): 1394–7. doi: 10.1248/bpb.28.1394
- Shi YC, Liao JW, Pan TM. Antihypertriglyceridemia and anti-inflammatory activities of monascus-fermented dioscorea in streptozotocin-induced diabetic rats. Exp Diabetes Res 2011; 2011: 710635. doi: 10.1155/2011/710635
- Dungan KM. 1,5-Anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn 2008; 8(1): 9–19. doi: 10.1586/14737126.96.36.199
- Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB. Serum 1, 5-anhydroglucitol (GlycoMark): a short-term glycemic marker. Diabetes Technol Ther 2003; 5(3): 355–63. doi: 10.1089/152091503765691839
- Seok H, Huh JH, Kim HM, Lee BW, Kang ES, Lee HC, et al. 1,5-Anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes. Diabetes Metab J 2015; 39(2): 164–70. doi: 10.4093/dmj.2015.39.2.164
- Biesenbach G. Disorders of lipid metabolism in diabetes mellitus. Wien Med Wochenschr 1989; 105(Suppl l): 9–17.
- Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999; 69(2): 231–6. doi: 10.1093/ajcn/69.2.231
- Thompson Coon JS, Ernst E. Herbs for serum cholesterol reduction: a systematic view. J Fam Pract 2003; 52(6): 468–78.
- Dryden S, Burns SJ, Frankish HM, Williams G. Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids. Eur J Pharmacol 1997; 340(2–3): 221–5. doi: 10.1016/s0014-2999(97)01410-6
- Chang JC, Wu MC, Liu IM, Cheng JT. Plasma glucose-lowering action of Hon-Chi in streptozotocin-induced diabetic rats. Horm Metab Res 2006; 38(2): 76–81. doi: 10.1055/s-2006-925116
- Koranyi LI, Bourey RE, Vuorinen-Markkola H, Koivisto VA, Mueckler M, Permutt MA, et al. Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia 1991; 34(10): 763–5. doi: 10.1007/bf00401526
- Zhao P, Tian D, Song G, Ming Q, Liu J, Shen J, et al. Neferine promotes GLUT4 expression and fusion with the plasma membrane to induce glucose uptake in L6 cells. Front Pharmacol 2019; 10: 999. doi: 10.3389/fphar.2019.00999
- Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest 2006; 116(7): 1767–75. doi: 10.1172/JCI29027
- Brial F, Alzaid F, Sonomura K, Kamatani Y, Meneyrol K, Le LA, et al. The natural metabolite 4-cresol improves glucose homeostasis and enhances β-cell function. Cell Rep 2020; 30(7): 2306–20.e5. doi: 10.1016/j.celrep.2020.01.066
- Yang Y, Kumrungsee T, Kuroda M, Yamaguchi S, Kato N. Feeding aspergillus protease preparation combined with adequate protein diet to rats increases levels of cecum gut-protective amino acids, partially linked to bifidobacterium and lactobacillus. Biosci Biotechnol Biochem 2019; 83(10): 1901–11. doi: 10.1080/09168451.2019.1627183
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to SNF Swedish Nutrition Foundation. Read the full Copyright- and Licensing Statement.